Abstract
The roles and safety of beta blockade following cardiac surgery have been controversial for three decades. In the 1960's and early 1970's it was feared that perioperative use of beta blockers would cause significant myocardial depression by either their direct antiadrenergic effects or the potentiation of the myocardial depressant effects of general anesthetics. Many recommended that beta blockers be discontinued from 48 hours [1,2] to as early as 2 weeks before surgery [3]. This practice was challenged after reports of worsening angina, myocardial infarction, ventricular tachycardia, and sudden death following the abrupt cessation of beta blockers in patients treated chronically with propranolol [4,5] as well as an increased incidence of perioperative complications in patients in whom beta blockers were discontinued preoperatively [6]. By the late 1970's the safety for continued beta blockade before and after cardiac surgery was demonstrated [7,8], and this strategy was tested for the prevention of postoperative complications, most often supraventricular arrhythmias. Herein we review the clinical trials testing various beta-adrenergic antagonists after cardiac surgery for the prevention of postoperative atrial fibrillation (Table 1) and offer recommendations for treatment. discontinuation 10 hours before surgery, or continuation of beta blockade until the day of surgery followed by low dose intravenous propranolol for 36 to 48 hours postoperatively. These three groups were compared also to 17 patients who did not receive propranolol either prior to or after surgery. The highest incidence of supraventricular arrhythmias was observed in the groups randomized to discontinuation of propranolol 48 or 10 hours before surgery when compared to the group receiving pre- and postoperative propranolol. The authors also noted a marked increase in the rate-pressure product during intubation and postoperative periods in the patients for whom the beta blocker was discontinued before surgery. The authors speculated that both findings were due to propranolol withdrawal following a hyperadrenergic response to stress.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Faulkner SL, Hopkins JT, Boerth RC, et al. Time required for complete recovery from chronic propranolol therapy. N Engl J M 1973;289:607–9.
Jones EL, Kaplan JA, Dorney ER, et al. Propranolol therapy in patients undergoing myocardial revascularization. Am J Cardiol 1976;38:696–700.
Viljoen JF, Estafanous FG, Kellner GA. Propranolol and cardiac surgery. J Thorac Cardiovasc Surg 1972;64:826–30.
Diaz RG, Somberg JC, Freeman E, et al. Withdrawal of propranolol and myocardial infarction. Lancet 1973;1:1068.
Miller RR, Olson HG, Amsterdam EA, et al. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of anti anginal therapy. N Engl J Med 1975;293:416–8.
Salazar C, Frishman W, Freidman S et al. Beta-blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome? Angiology 1979;30:816–9.
Boudolas H, Snyder GL, Lewis RP, et al. Safety and rationale for continuation of propranolol therapy during coronary bypass operation. Ann Thorac Surg 1978;26:222–29.
Kirsh MM, Douglas MB, Jackson AP, et al. Myocardial revascularization in patients receiving long-term propranolol therapy. Ann Thorac Surg 1978;25:117–21.
Oka Y, Frisman W, Becker RM. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 10. Beta-adrenoreceptor blockade and coronary artery surgery. Am Heart J 1980;99:255–69.
Stephenson LW, MacVaugh H, Tomasselo DN, Josephson ME. Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. Ann Thorac Surg 1980;29:113–6.
Mohr R, Smolonsky A, Goor DA. Prevention of supraventricular tachyarrhythmias with low-dose propranolol after coronary bypass. J Thorac Cardivasc Surg 1981;81:841–5.
Silverman NA, Wright R, Levitsky S. Efficacy of low dose propranolol in preventing postoperative supraventricular tachyarrhythmias: a prospective, randomized study. Ann Surg 1982; 196:194–7.
Abel RM, Van Gelder H, Pores IH, Liguori J, Gielchinski I, Parsonnet V. Continued propranolol administration following coronary bypass surgery: antiarrhythmic effects. Arch Surg 1983;118:727–31.
Ivey MF, Ivey TD, Bailey WW, Williams DB, Hessel EA II, Miller DW Jr. Influence of propranolol on supraventricular tachycardia early after coronary ravascularization: a randomized trial. J Thorac Cardiovasc Surg 1983;85:214–8.
Hammond JW Jr, Wood AJ, Prager RL, Wood M, Muirhead J, Bender HW Jr. Perioperative beta blockade with propranolol: Reduction in myocardial oxygen demands and incidence of atrial and ventricular arrhythmias. Ann Thorac Surg 1984;38:363–7.
Matangi MF, Neutze JM, Graham KJ, Hill DG, Kerr AR, Barrat-Boyes BG. Arrhythmia prophylaxis after aorta-coronary bypass. The effect of mini dose propranolol. J Thorac Cardiovasc Surg 1985;89:439–43
Martinussen HJ, Lolk A, Szczepanski C, Alstrup P. Supraventricular tachyarrhythmias after coronary bypass surgery-a double-blind randomized trial of prophylactic low dose propranolol. Thorac Cardiovasc Surg 1988;36:206–7.
Shafei H, Nashef SA, Turner MA, Brian WH. Does low-dose propranol reduce the incidence of supraventricular tachyarrhythmias following myocardial revascularization? A clinical study. Thorac Cardiovasc Surg 1988;36:202–5.
Ormerod OJM, McGregor CGA, Stone DL, Wisbey C, Petch MC. Arrhythmias after coronary bypass surgery. Br. Heart J 1984;51:618–21.
Rubin DA, Nieminski KE, Reed GE, Herman MV. Predictors, prevention, and long term prognosis of atrial fibrillation after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 1987;94:331–5.
Mills SA, Poole GV, Breyer RH et al. Digoxin and propranolol in the prophylaxis of dysrythmias after coronary bypass grafting. Circulation 1983;68:Suppl II:II-222–II-225.
Kendall MJ. Are selective beta-adrenoreceptor blocking drugs an advantage? J R Coll Phys Lond 1981;15:33–40.
White HD, Antman EM, Glynn MA, et al. Efficacy and safety of timolol for prevention of supraventricular lachyarrhythmias after coronary bypass surgery. Circulation 1984;70:479–84.
Vecht RJ, Nicolaides EP, Ikweuke JK, Liassides C, Cleary J, Cooper WB. Incidence and prevention of supraventricular tachycardias after coronary bypass surgery. Int J Cardiol 1986; 13:125–34.
Daudon P, Corcos T, Gandjbakhch I, Levasseur JP, Cabrol A, Cabrol C. Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. Am J Cardiol 1986;58:933–6.
Materne P, Larbuisson R, Collignon P, Limet R, Kulbertus H. Prevention by acebutolol of rhythm disorders following coronary artery bypass surgery. Int J Cardiol 1985;8:275–283.
Khuri SF, Okike N, Josa M et al. Efficacy of nadolol in preventing supraventricular tachycardia after coronary bypass grafting. Am J Cardiol 1987;60:51D–58D.
Lamb RK, Prabhakar G, Thorpe JAC, Smith S, Norton R, Dyde JA. The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery. Eur Heart J 1988;9:32–6.
Matangi MM, Strickland J, Garbe GJ, et al. Atenolol for the prevention of arrhythmias following coronary artery bypass grafting. Can J Cardiol 1989;5:229–34.
Janssen J, Loomans L, Harink L, et al. Prevention and treatment of supraventricular tachycardia shortly after coronary bypass grafting: a randomized open trial. Angiology 1986;37:601–9.
Kowey PR, Taylor JE, Rials SJ, Marinchak RA. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol 1992;69:963–65.
Andrews TC, Reimold SC, Berlin JA, Antman EA. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation 1991;84:Suppl III:III-236–III-244.
Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335–71.
Bush HL Jr., Gelband H, Hoffman BF, Malm JR. Electrophysiological basis for supraventricular arrhythmias following surgical procedures for aortic stenosis. Arch Surg 1971;103:620–5.
Hoie J, Forfang K. Arrhythmias and conduction disturbances following aortic valve implantation. Scand J Thor Cardiovasc Surg 1980;14:177–83.
Creswell LL, Rosembloom M, Schuessler RB, Cox JL. Atrial arrhythmias after cardiac surgical procedure: An updated examination of risk factors. J Am Coll Cardiol 1993;21:122A. abstract.
Douglas P, Hishfeld JW Jr, Edmunds LH. Clinical correlates of postoperative atrial fibrillation. Circulation 1984;70:Suppl II:II–165. abstract.
Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery. Predictors, outcome, and resource utilization. JAMA 1996;276:300–6.
Lauer MS, Eagle KA, Buckley MJ, DeSanctis RW. Atrial fibrillation following coronary bypass surgery. Prog Cardiovasc Dis 1989;5:367–78.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Kluwer Academic Publishers
About this chapter
Cite this chapter
Sanchez, J.E., Epstein, A.E. (2000). Prophylactic Value of Beta Blockers. In: Steinberg, J.S. (eds) Atrial Fibrillation after Cardiac Surgery. Developments in Cardiovascular Medicine, vol 222. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-28007-3_6
Download citation
DOI: https://doi.org/10.1007/978-0-585-28007-3_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-7923-8655-1
Online ISBN: 978-0-585-28007-3
eBook Packages: Springer Book Archive